Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

The Power of Advocacy

Blair Solow, MD  |  January 10, 2022

While working on a 1,000-piece puzzle of our country’s national parks (a 2020 Christmas present from my sister—and yes, I intend to finish soon!), I wondered how these great lands came to be protected for all to enjoy. I learned that President Theodore Roosevelt in 1901 spent significant time and resources to develop the U.S. Forest Service and lay the groundwork for what would become the National Park System. “We have fallen heirs to the most glorious heritage a people ever received, and each one must do his part if we wish to show that the nation is worthy of its good fortune,” he said.1

Blair Solow, MD

Dr. Solow

During his tenure, President Roosevelt protected 230 million acres of public land. In 1915–16, a handful of conservation advocates amassed support and successfully lobbied Congress to develop the National Park System, which now comprises more than 85 million acres, roughly 3% of U.S. land.2,3

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The men (since of course it was all men at that time) who protected the U.S. wildlands knew that having a seat at the table—whether in an office or in the park—was necessary to make bold strides in advocating for public lands.2 The same is true for moving health policy forward in 2022. Consider making a RheumPAC investment this year to help enable nonpartisan meetings with lawmakers working on issues that impact rheumatology patients and our profession.

In my final year as chair of the Government Affairs Committee (GAC), I would like to give an immense thank you to our GAC members, patients, physicians and interprofessional team members for making virtual advocacy a huge success. I also feel extraordinarily lucky to work with our ACR advocacy team,  including Lennie Shewmaker McDaniel, JD, director of congressional affairs; Amanda Grimm Wiegrefe, MScHSRA, director of regulatory affairs; and Dan Redinger, director of political affairs and engagement, in Washington, D.C., and Joseph Cantrell, JD, senior manager of state affairs; Adam Cooper, vice president of practice, advocacy and quality; and the rest of the team in the Atlanta office.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

As we look to 2022, we can expect the second year of the 117th Congress to be shaped by our 2021 experiences with large spending bills and top-down legislation formulated in the midst of the COVID-19 pandemic.

2022 Physician Fee Schedule Final Rule

Each year, the Centers for Medicare & Medicaid Services (CMS) releases rules on physician reimbursement. It uses recommendations from the AMA Relative Value Schedule Update Committee (RUC) to guide decisions on how to pay physicians from a single pot of money. In 2021, the CMS increased the value of certain Current Procedural Terminology (CPT) codes, including those often used by subspecialties, and modified documentation requirements to reduce administrative burdens. In the 2022 Physician Fee Schedule (PFS) Final Rule, rheumatologists maintained a boost in reimbursement. In this zero-sum game, other specialties were not as fortunate, with losses in surgery, radiology and physical therapy.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:Legislation & Advocacy Tagged with:ACR advocacyAdvocacyBuild Back Better ActLegislationMedicare reimbursement ratePediatric Subspecialty Loan Forgivenesspharmacy benefit managers (PBMs)Research Fundingstate legislationstep therapy legislationtelehealthWorkforce

Related Articles

    Telehealth Brings Opportunities to Enhance Patient Care

    December 8, 2022

    During an ACR webinar in August, presenters discussed multiple aspects of telehealth in rheumatology, especially related to rheumatology fellowship training. They agreed that although telehealth represents one potential avenue to improve patient access to treatment for rheumatic disease, we must keep identifying the best ways to employ telehealth to enhance care. Impact of Pandemic Telemedicine…

    What’s Next for Telehealth after the COVID-19 Public Health Emergency?

    June 10, 2023

    Do you remember where you were when the COVID-19 Public Health Emergency (PHE) was declared on Jan. 31, 2020? While it may seem like yesterday, you would be forgiven for not recalling your exact location over three years ago during what felt like an incredible whirlwind for the healthcare industry. One possible location you may…

    Telerheumatology: What’s Next?

    December 17, 2020

    In an ACR Convergence session, two rheumatologists discussed how COVID-19 changed the use of telemedicine, how payers reacted and which changes are likely permanent and which are likely to be temporary.

    ACR Advocacy: 2020 Year in Review

    January 11, 2021

    As a new year begins, Government Affairs Committee Chair Blair Solow, MD, takes stock of ACR advocacy wins in 2020 and issues to watch in 2021, including workforce issues, continued telemedicine access, prior authorization relief, Medicare reimbursement and drug pricing.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences